autoimmune disease and semaglutide Weight loss, activity, patient reported outcomes in patients with musculoskeletal and diseases taking weight loss medications: a retrospective cohort study Mixed Connective Tissue Disease (MCTD)
Description
In addition, the drug was found to restore other liver markers and reduce body weight by 10.5%, versus just 2% in the placebo group
They're moderating with intention
Rare side effects, such as gallbladder issues or pancreatitis, may require discontinuation of the medication, she explains
Both are available without insurance, membership fees, or prior authorization, and both qualify for HSA/FSA accounts, making personalized GLP-1 therapy accessible to patients across all 50 states
This is a type of study that looks at separate clinical trials
Dentists should take a thorough medical history and screening for such medications
